Embedding ‘speaking up’ into systems for safe healthcare product development and marketing surveillance (January 2013)

Summary

This article, published in Drug Safety, Robust, argues that active cooperation and effective, open communication between all stakeholders is essential for ensuring regulatory compliance and healthcare product safety; avoiding the necessity for whistle-blowing; and, most essentially, meeting the transparency requirements of public trust.